Lyka Labs Reports Strong Financial Growth, Signaling Positive Trends in Pharmaceuticals Sector

Lyka Labs, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 26, 2025, indicate a notable shift in the company's evaluation, with the score rising to 20 from 16 over the past three months. The financial data reveals significant growth in key metrics. Profit Before Tax (PBT), excluding other income, reached Rs 2.20 crore, reflecting a substantial year-on-year increase of 213.40%. Similarly, Profit After Tax (PAT) stood at Rs 2.03 crore, marking a year-on-year growth of 196.2%. Additionally, net sales for the quarter amounted to Rs 33.43 crore, which represents a year-on-year increase of 20.38%. These results suggest a favorable trend for Lyka Labs, highlighting strong performance across various financial indicators. The recent evaluation changes reflect the company's positive trajectory in the competitive pharmaceutical landscape. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.